Patent ID: 6887660

Claim:
A method for detecting prostate cancer in a patient comprising: (a) obtaining a biological sample from the patient; (b) contacting the sample with at least two oligonucleotide primers in a polymerase chain reaction, wherein said oligonucleotide primers are specific for nucleotide residues 1341-2694 of SEQ ID NO:110 an full length complements of nucleotide residues 1341-2694 of SEQ ID NO:110; and (c) detecting in the sample an expressed polynucleotide sequence that amplifies in the presence of the oligonucleotide primers thereby detecting prostate cancer, wherein the biological sample is selected from the group consisting of blood and semen; wherein the oligonucleotide primers consist of fragments of nucleotide residues 1341-2694 of SEQ ID NO:110; and wherein the fragments consist of at least about 10 contiguous nucleotides of nucleotide residues 1341-2694 of SEQ ID NO:110, or full length complements of nucleotide residues 1341-2694 of SEQ ID NQ:110.